parallel randomized trial

S003440

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

Polycystic ovary syndromeS003440

Design

Randomized: 200
Start year
Treatment: 26.07 weeks, follow-up 26.07 weeks
Countries
Sponsor: (not reported)
Eligibility: obese women with PCOS 25 to 40 years; weight 70 to 110 kg; failed induction and IVF; declined sleeve gastrectomy

Conduct and analysis

Blinding: open label
Sequence generation: not reported
Allocation concealment: not reported
Outcome adjudication: not reported
Primary estimand: not stated
Analysis population
Missing data

Arms

Arm	Treatment	Background	Randomized	Analyzed	Completed treatment
A1	dulaglutide Group A dulaglutide plus calorie restricted diet	vitamin D and folic acid; lifestyle: intensive	100
A2	Metformin Group B metformin (Glucophage)	vitamin D and folic acid; lifestyle: intensive	100

Results

2 adjudicated result lines, grouped by outcome. Open an outcome to see its values.

Regular menstrual cycles (2 lines; O90B)

Week	Arm	Statistic	Estimate	SE or SD	95% CI	Events / N	Detail
26.07	A1	responders	95				not stated; other; R0048351:Results
26.07	A2	responders	75				not stated; other; R0048351:Results